Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by mbuchon Oct 24, 2018 2:49pm
199 Views
Post# 28865734

APH should settle down to the $10 range even with NYSE news

APH should settle down to the $10 range even with NYSE newsThen an investor will come in and pop the price up to $12-$15 if you're lucky. But that won't even last for long.  Wait for 5 years or so. Whole sector is too overvalued.

All Vic's plan to screw the retail investor and give the institutional investors what they want. He never wanted to join the hype and give us a chance to cash in...






Bullboard Posts